Lihan Zhang
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Development and external validation of a nomogram for predicting the risk of developing esophageal cancer based on a questionnaire: a multicenter case-control study.
Journal: Frontiers in oncology
Published: August 12, 2025
Identification of Epinastine as CD96/PVR inhibitor for cancer immunotherapy.
Journal: BMC biology
Published: May 08, 2024
The causality between Type 2 diabetes and breast cancer: a bidirectional two-sample Mendelian randomization study.
Journal: Future oncology (London, England)
Published: April 19, 2024
Nanodrugs systems for therapy and diagnosis of esophageal cancer.
Journal: Frontiers in bioengineering and biotechnology
Published: June 02, 2023
Identification of a novel small-molecule inhibitor targeting TIM-3 for cancer immunotherapy.
Journal: Biochemical pharmacology
Published: March 27, 2023
Peptide vaccine from cancer-testis antigen ODF2 can potentiate the cytotoxic T lymphocyte infiltration through IL-15 in non-MSI-H colorectal cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: August 26, 2022
Apatinib combined with PD-1 antibody for third-line or later treatment of advanced gastric cancer.
Journal: Frontiers in oncology
Published: May 25, 2022
Tissue factor potentiates adherence of breast cancer cells to human umbilical vein endothelial cells under static and flow conditions.
Journal: Cell adhesion & migration
Published: March 18, 2021
CD276 suppresses CAR-T cell function by promoting tumor cell glycolysis in esophageal squamous cell carcinoma.
Journal: Journal of gastrointestinal oncology
Published: March 12, 2021
PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors.
Journal: Breast cancer research : BCR
Published: November 03, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026